查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1777478

全球早产及胎膜早破检测市场

Preterm Birth and PROM Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 293 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球早产和胎膜早破检测市场规模将达 23 亿美元

全球早产和胎膜早破（PROM）检测市场规模预计在2024年为15亿美元，到2030年预计将达到23亿美元，在2024-2030年的分析期内，复合年增长率为7.4%。骨盆腔检查是本报告分析的细分市场之一，预计其复合年增长率为8.8%，到分析期结束时市场规模将达到7.017亿美元。胎儿纤连蛋白检测细分市场在分析期间的复合年增长率预计为8.1%。

美国市场规模估计为 4.05 亿美元，中国市场预计复合年增长率为 11.7%

美国早产和胎膜早破（PROM）检测市场规模预计在2024年达到4.05亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到4.859亿美元，在2024-2030年的分析期间内，复合年增长率为11.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.6%和7.2%。在欧洲，预计德国市场的复合年增长率为4.9%。

全球早产和胎膜早破检测市场—主要趋势和驱动因素摘要

早产和胎膜早破检测如何改善产妇和新生儿护理？

早产和胎膜早破 (PROM) 检测已成为产妇保健的重要工具，可实现对影响胎儿发育和新生儿存活的併发症的早期诊断和风险评估。早产是指妊娠 37 週前分娩，是全世界新生儿死亡和发病的主要原因之一。胎膜早破（分娩开始前羊膜囊自然破裂）会显着增加感染疾病、早产和新生儿併发症的风险。先进的诊断方法，如基于生物标记的检测、胎儿纤连蛋白(fFN) 检测和照护现场(POC) 解决方案，正在改变临床医生预测和管理早产的方式。快速诊断工具在产科护理中的整合已经导致了决策的改进、及时干预和更好的怀孕结果。随着医疗保健系统将重点放在降低早产率和提高新生儿存活率上，早产和胎膜早破检测已成为产科医院、诊所和高风险妊娠监测计画的重要组成部分。

影响早产和胎膜早破检测采用的挑战有哪些？

儘管早产和胎膜早破检测至关重要，但其推广应用仍面临许多挑战，影响市场扩张和可及性。其中一个主要问题是先进诊断检测的成本，这使得它们在资源匮乏、孕产妇保健基础设施有限的地区难以普及。此外，检测准确性参差不齐和假阳性率高低可能导致不必要的住院、类固醇和紧急药物的使用，以及医疗成本的增加。由于早产风险管理通讯协定因医疗体係而异，缺乏统一实施这些检测的标准化指南，进一步加剧了临床决策的复杂性。另一个挑战是产妇对早产和胎膜早破检测的认知度有限，导致诊断和介入延迟。此外，监管核准和严格的临床检验要求也阻碍了创新检测解决方案的商业化，并降低了市场应用率。应对这些挑战需要持续的研究、经济高效的检测开发以及有针对性的宣传活动，以加强对医护人员和患者的教育。

诊断创新如何改变早产和胎膜早破检测

母胎诊断技术的进步彻底改变了早产和胎膜早破检测，提高了准确性、效率和可及性。基于胎盘α-微球蛋白-1（PAMG-1）和胰岛素样生长因子结合蛋白-1（IGFBP-1）等非侵入性生物标记检测的开发，提高了高灵敏度和特异性检测胎膜早破的能力。人工智慧预测分析和机器学习演算法也被整合到孕产妇健康监测中，使临床医生能够使用患者病历、生理数据和即时生物标记追踪来评估早产风险。可携式和即时检测设备使偏远和欠发达地区更容易获得诊断，从而能够对高风险妊娠进行早期疗育。远端医疗和数位健康平台的兴起进一步提高了早产诊断的可用性，为孕妇提供了即时咨询和个人化风险评估的机会。随着精准医疗在产科护理中变得越来越普遍，早产和胎膜早破检测将变得更加复杂，从而能够制定个人化的治疗策略并改善周产期结果。

是什么推动了早产和胎膜早破检测市场的成长？

早产和胎膜早破检测市场的成长受到多种因素的推动，包括全球早产率的上升、孕产妇保健诊断技术的进步以及就地检验解决方案的日益普及。人们越来越重视降低新生儿死亡率和发病率，这加速了对早期和准确的早产检测方法的需求，从而导致对创新诊断技术的投资增加。随着医疗保健提供者优先考虑早期筛检和干预策略，母胎医学计画和高风险妊娠诊所的扩展进一步推动了市场的成长。此外，政府为改善孕产妇健康所采取的措施和提供的资金正在推动公共医疗系统采用先进的检测解决方案。医疗保健的快速数位化和人工智慧在妊娠监测中的整合也使得更准确、更容易取得的风险评估工具成为可能，从而创造了新的市场机会。随着对个人化孕产妇保健的需求持续增长，早产和胎膜早破检测市场预计将经历持续增长，并透过早期诊断和有针对性的干预措施改变孕产妇保健。

部分

检查类型（骨盆检查、超音波、生化标记、子宫监测检查、尼替丁检查、胎儿子宫内试验、合併试验、PAMG-1免疫检测检查、IGFBP检查、胎儿纤连蛋白检查、其他检查类型）、目的（PROM、早产、绒毛膜羊膜炎）

受访公司范例

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP32688

Global Preterm Birth and PROM Testing Market to Reach US$2.3 Billion by 2030

The global market for Preterm Birth and PROM Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Pelvic Exam Test, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$701.7 Million by the end of the analysis period. Growth in the Fetal Fibronectin Test segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$405.0 Million While China is Forecast to Grow at 11.7% CAGR

The Preterm Birth and PROM Testing market in the U.S. is estimated at US$405.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$485.9 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Preterm Birth and PROM Testing Market - Key Trends & Drivers Summarized

How Is Preterm Birth and PROM Testing Improving Maternal and Neonatal Care?

Preterm birth and premature rupture of membranes (PROM) testing have become essential tools in maternal healthcare, enabling early diagnosis and risk assessment for complications that can impact fetal development and neonatal survival. Preterm birth, defined as delivery before 37 weeks of gestation, is one of the leading causes of neonatal mortality and morbidity worldwide. Premature rupture of membranes, the spontaneous breaking of the amniotic sac before labor begins, significantly increases the risk of infection, preterm delivery, and neonatal complications. Advanced diagnostic methods, including biomarker-based assays, fetal fibronectin (fFN) tests, and point-of-care (POC) testing solutions, are transforming the way clinicians predict and manage preterm labor. The integration of rapid diagnostic tools in obstetric care has led to improved decision-making, timely interventions, and better pregnancy outcomes. As healthcare systems focus on reducing preterm birth rates and improving neonatal survival, preterm birth and PROM testing are becoming indispensable in maternity hospitals, clinics, and high-risk pregnancy monitoring programs.

What Challenges Are Affecting the Adoption of Preterm Birth and PROM Testing?

Despite its importance, the adoption of preterm birth and PROM testing faces several challenges that impact market expansion and accessibility. One of the primary concerns is the cost associated with advanced diagnostic tests, making them less accessible in low-resource settings where maternal healthcare infrastructure is limited. Additionally, the variability in test accuracy and false-positive rates can lead to unnecessary hospitalizations, administration of steroids or tocolytics, and increased healthcare costs. The lack of standardized guidelines for the universal implementation of these tests further complicates clinical decision-making, as different healthcare systems adopt varying protocols for managing preterm labor risk. Another challenge is the limited awareness among expectant mothers regarding the availability of preterm birth and PROM tests, leading to delayed diagnosis and intervention. Moreover, regulatory approvals and stringent clinical validation requirements slow down the commercialization of innovative testing solutions, delaying widespread market adoption. Addressing these challenges requires continuous research, cost-effective test development, and targeted awareness campaigns to enhance healthcare provider and patient education.

How Are Innovations in Diagnostic Technologies Transforming Preterm Birth and PROM Testing?

Technological advancements in maternal-fetal diagnostics are revolutionizing preterm birth and PROM testing, improving accuracy, efficiency, and accessibility. The development of non-invasive and biomarker-based assays, such as placental alpha-microglobulin-1 (PAMG-1) and insulin-like growth factor-binding protein-1 (IGFBP-1) tests, has enhanced the ability to detect PROM with high sensitivity and specificity. AI-powered predictive analytics and machine learning algorithms are also being integrated into maternal health monitoring, allowing clinicians to assess preterm birth risk using patient history, physiological data, and real-time biomarker tracking. Portable and point-of-care testing devices are making diagnostics more accessible in remote and underdeveloped regions, enabling early intervention in at-risk pregnancies. The rise of telemedicine and digital health platforms is further enhancing the reach of preterm birth diagnostics, allowing pregnant women to access real-time consultations and personalized risk assessments. As precision medicine gains traction in obstetric care, preterm birth and PROM testing are expected to become more sophisticated, enabling tailored treatment strategies and improved perinatal outcomes.

What Is Driving the Growth of the Preterm Birth and PROM Testing Market?

The growth in the preterm birth and PROM testing market is driven by several factors, including increasing global preterm birth rates, advancements in maternal healthcare diagnostics, and the rising adoption of point-of-care testing solutions. The growing focus on reducing neonatal mortality and morbidity has accelerated the demand for early and accurate preterm birth detection methods, leading to increased investment in innovative diagnostic technologies. The expansion of maternal-fetal medicine programs and high-risk pregnancy clinics has further fueled market growth, as healthcare providers prioritize early screening and intervention strategies. Additionally, government initiatives and funding for maternal health improvement are promoting the adoption of advanced testing solutions in public healthcare systems. The rapid digitalization of healthcare and the integration of AI in pregnancy monitoring are also creating new market opportunities, enabling more precise and accessible risk assessment tools. As demand for personalized maternal healthcare continues to rise, the preterm birth and PROM testing market is expected to experience sustained growth, transforming prenatal care through early diagnosis and targeted interventions.

SCOPE OF STUDY:

The report analyzes the Preterm Birth and PROM Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Pelvic Exam Test, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test, IGFBP Test, Fetal Fibronectin Test, Other Test Types); Application (PROM Application, Preterm Labor Application, Chorioamnionitis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preterm Birth and PROM Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Preterm Births Throws the Spotlight on Early and Accurate Diagnostic Solutions
    • Growing Clinical Awareness Around Premature Rupture of Membranes (PROM) Drives Adoption of Specialized Testing Tools
    • Advancements in Biomarker-Based Diagnostic Platforms Spur Innovation in Rapid and Non-Invasive PROM Detection
    • Increased Emphasis on Risk Stratification and Preventive Obstetric Care Strengthens Business Case for Early PROM Screening
    • Expansion of Point-of-Care Testing Technologies Propels Growth in Decentralized and Immediate PROM Diagnosis
    • Rising Maternal Age and Associated Pregnancy Complications Drive Demand for Predictive Preterm Birth Testing
    • Integration of Molecular Diagnostic Techniques Enhances Sensitivity and Specificity of PROM and Preterm Risk Assessments
    • Growth in Hospital-Acquired Infection Control Programs Spurs Interest in Minimally Invasive and Accurate Testing Devices
    • Development of Amniotic Fluid-Specific Detection Reagents Generates Demand for Targeted PROM Identification Tools
    • Expansion of Neonatal Intensive Care Units (NICUs) Strengthens Investment in Prenatal Risk Management Solutions
    • Emergence of Multiplex Testing Panels Accelerates Adoption of Combined PROM and Preterm Birth Diagnostic Kits
    • Regulatory Endorsements and Clinical Guidelines Drive Standardization of PROM and Preterm Testing Protocols
    • Rising Penetration of Digital Health and Remote Monitoring Platforms Spurs Innovation in At-Home PROM Test Accessibility
    • Increased Collaboration Between Diagnostic Companies and Obstetric Research Institutes Propels Evidence-Based Product Development
    • Growing Health Infrastructure in Emerging Markets Expands Access to Low-Cost, High-Efficacy PROM Testing Solutions
    • Surge in Demand for Rapid Diagnostics in Emergency Obstetric Settings Drives Point-of-Care Market Momentum
    • Heightened Focus on Reducing Neonatal Morbidity and Mortality Strengthens Value Proposition of Early PROM Detection
    • Government Funding and Public Health Campaigns Targeting Maternal Health Accelerate PROM Testing Program Implementation
    • Adoption of AI-Enabled Diagnostic Algorithms Enhances Interpretation Accuracy and Decision Support in High-Risk Pregnancies
    • Rising Consumer Awareness of Maternal-Fetal Health Drives Uptake of PROM and Preterm Screening in Private Clinics
    • Increased Commercialization of Disposable Diagnostic Devices Supports Infection Control and Compliance in Hospital Settings
    • Challenges in Reimbursement for Newer PROM Testing Technologies Spur Innovation in Cost-Effective Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preterm Birth and PROM Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pelvic Exam Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Fetal Fibronectin Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ultrasound Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochemical Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Uterine Monitoring Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nitazine Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ferning Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pooling Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for PAMG-1 Immunoassay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for IGFBP Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for PROM Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Preterm Labor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Chorioamnionitis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CHINA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • INDIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030

IV. COMPETITION